Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro1

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,736

The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death

Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,909

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789

Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6

Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B. F., Broxmeyer, H. E., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,440

SRα Promoter: an Efficient and Versatile Mammalian cDNA Expression System Composed of the Simian Virus 40 Early Promoter and the R-U5 Segment of Human T-Cell Leukemia Virus Type 1 Long Terminal Repeat

Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M., & Arai, N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.466-472.1988 · Cited by 1,330

A novel domain within the 55 kd TNF receptor signals cell death

Tartaglia, L. A., Ayres, T. M., Wong, G. H., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,290

Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule

Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,108

Modulation of Osteoclast Differentiation

Suda, T., Takahashi, N., & Martin, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004

OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION

Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-123-5-2600 · Cited by 934

Osteoprotegerin and bone mineral metabolism in renal failure

Kazama, J. J. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000133982.40182.8a · Cited by 23

Potential of creatine supplementation for improving aging bone health

Candow, D. G., & Chilibeck, P. D. (2010) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0224-5 · Cited by 22

Osteoprotegerin ameliorates sciatic nerve crush induced bone loss.

Bateman, T. A., Dunstan, C. R., Lacey, D. L., Ferguson, V. L., Ayers, R. A., & Simske, S. J. (2001) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(00)00057-7 · Cited by 22

Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts.

Doran, P. M., Turner, R. T., Chen, D., Facteau, S. M., Ludvigson, J. M., Khosla, S., Riggs, B. L., & Russell, S. J. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.01.006 · Cited by 22

Oral microbiota–host interaction: the chief culprit of alveolar bone resorption

Xu, J., Yu, L., Ye, S., Ye, Z., Yang, L., & Xu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1254516 · Cited by 22

Conjugated Linoleic Acid Prevents Ovariectomy‐Induced Bone Loss in Mice by Modulating Both Osteoclastogenesis and Osteoblastogenesis

Rahman, M. M., Fernandes, G., & Williams, P. (2013) · Lipids · doi:10.1007/s11745-013-3872-5 · Cited by 21

PTH and PTHrP Actions on Kidney and Bone

Bisello, A., & Friedman, P. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00050-1 · Cited by 23

Autophagy: A Promising Target for Age-related Osteoporosis

Wang, T., He, H., Liu, S., Jia, C., Fan, Z., Zhong, C., Yu, J., Liu, H., & He, C. (2018) · Current Drug Targets · doi:10.2174/1389450119666180626120852 · Cited by 24

STATs and macrophage fusion

Miyamoto, T. K. (2013) · JAK-STAT · doi:10.4161/jkst.24777 · Cited by 24

Osteoclastogenesis in the nonadherent cell population of human bone marrow is inhibited by rhBMP‐2 alone or together with rhVEGF

Wan, C., He, Q., & Li, G. (2005) · Journal of Orthopaedic Research® · doi:10.1002/jor.20010 · Cited by 22

High-phosphorus diet stimulates receptor activator of nuclear factor-κB ligand mRNA expression by increasing parathyroid hormone secretion in rats

Katsumata, S.-I., Masuyama, R., Uehara, M., & Suzuki, K. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20051552 · Cited by 23

A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima‐media thickness of the carotid artery in hypertensive patients. The Swedish irbesartan left ventricular hypertrophy investigation vs atenolol (SILVHIA)

Brändström, H., Stiger, F., Kahan, T., Melhus, H., Nyström, F. H., Öhman, K. P., Malmqvist, K. K., Lind, L., & Kindmark, A. (2004) · Blood Pressure · doi:10.1080/08037050410035563 · Cited by 22

Emerging and future therapies for the treatment of bone loss associated with chronic inflammation

Haynes, D. R. (2006) · Inflammopharmacology · doi:10.1007/s10787-006-0006-1 · Cited by 22

Expression and functional activity of osteoprotegerin in human malignant gliomas

Naumann, U., Wick, W., Beschorner, R., Meyermann, R., & Weller, M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0772-4 · Cited by 22

The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone loss.

Yeung, R. S. M. (2004) · PubMed · Cited by 22

Regenerative effect of hOPG gene-modified autologous PDLs in combination with cell transplantation on periodontal defection in beagle dogs

Jiang, S., Tang, K., Chen, B., & Yan, F. (2016) · Cytotechnology · doi:10.1007/s10616-016-9985-y · Cited by 21

Calcium Phosphate Ceramics and Synergistic Bioactive Agents for Osteogenesis in Implant Dentistry

Xu, C., Sun, Y., Jansen, J. A., Li, M., Wei, L., Wu, Y., & Liu, Y. (2023) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2023.0042 · Cited by 21

Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome

Camozzi, V., Sanguin, F., Albigier, N., Scaroni, C. M., Mantero, F., Zaninotto, M., Frigo, A., Piccolo, M., & Luisetto, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0800 · Cited by 22

Cancer Pain: From the Development of Mouse Models to Human Clinical Trials

Kruger, L., & Light, A. R. (2009) · CRC Press eBooks · doi:10.1201/9781439812105-9 · Cited by 21

Flavonoids compounds from Tridax procumbens inhibit osteoclast differentiation by down‐regulating c‐Fos activation

Mamun, M. A. A., Asim, M. M. H., Sahin, M. A. Z., & Al‐Bari, M. A. A. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14948 · Cited by 21

Effects of dexamethasone on tooth eruption in rats: Differences in incisor and molar eruption

Wise, G. E., Grier, R. L., Lumpkin, S. J., & Zhang, Q. (2001) · Clinical Anatomy · doi:10.1002/ca.1034 · Cited by 21

The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-γ gene with serum osteoprotegerin levels in healthy Korean women

Rhee, E., Oh, K.-W., Yun, E.-J., Jung, C., Park, C., Lee, W., Oh, E.-S., Baek, K., Kang, M.-I., Park, S. W., et al. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.76 · Cited by 21

Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption

The American Society for Bone and Mineral Research President’s Committee on Nomenclature (2000) · Bone · doi:10.1016/s8756-3282(00)00420-8 · Cited by 21

Osteoprotegerin

Feige, U. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.90003.iii81 · Cited by 22

Bioactive coatings with anti-osteoclast therapeutic agents for bone implants: Enhanced compliance and prolonged implant life

Bjelić, D., & Finšgar, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106060 · Cited by 20

Localization of RANK, RANKL and osteoprotegerin during healing of surgically created periodontal defects in sheep

Baharuddin, N. A., Coates, D. E., Cullinan, M. P., Seymour, G. J., & Duncan, W. (2014) · Journal of Periodontal Research · doi:10.1111/jre.12196 · Cited by 20

Gene Expression Profiles in Human and Mouse Primary Cells Provide New Insights into the Differential Actions of Vitamin D3 Metabolites

Tuohimaa, P., Wang, J., Khan, S., Kuuslahti, M., Qian, K., Manninen, T., Auvinen, P., Vihinen, M., & Lou, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075338 · Cited by 20

Feasibility of ceramic-polymer composite cryogels as scaffolds for bone tissue engineering

Rodríguez-Lorenzo, L. M., Saldaña, L., Benito-Garzón, L., Carrodeguas, R. G., Aza, S. D., Vilaboa, N. E., & Román, J. S. (2011) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.443 · Cited by 20

The loss of STAT3 in mature osteoclasts has detrimental effects on bone structure

Davidson, R. K., Himes, E. R., Takigawa, S., Chen, A. B., Horn, M. R., Meijome, T. E., Wallace, J. M., Kacena, M. A., Yokota, H., Nguyen, A. V., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236891 · Cited by 20

Preparation of novel (Z)-4-ylidenebenzo[b]furo[3,2-d][1,3]oxazines and their biological activity

Tabuchi, Y., Ando, Y., Kanemura, H., Kawasaki, I., Ohishi, T., Koida, M., Fukuyama, R., Nakamuta, H., Ohta, S., Nishide, K., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.04.017 · Cited by 20

Osteoprotegerin and receptor activator of nuclear factor‐κB ligand system in the early post‐operative period of liver transplantation

Fábrega, E., Orive, A., García‐Unzueta, M. T., Amado, J., Casafont, F., & Pons‐Romero, F. (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2006.00497.x · Cited by 20

Analysis of the association of polymorphism in the osteoprotegerin gene with susceptibility to chronic kidney disease and periodontitis

Baioni, C. S., Souza, C. M., Braosi, A. P. R., Luczyszyn, S. M., da Silva, M. A. D., Ignácio, S. A., Machado, M. Â. N., Martins, W. D. B., RIELLA, M. C., Pecoits‐Filho, R., et al. (2008) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2008.01098.x · Cited by 19

The neuro-osteogenic network: The sympathetic regulation of bone resorption

Togari, A., Arai, M., Kondo, H., Kodama, D., & Niwa, Y. (2012) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2011.12.002 · Cited by 20

Bone health in pediatric rheumatic disease

Rouster‐Stevens, K. A., & Klein‐Gitelman, M. S. (2005) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000184048.13263.88 · Cited by 20

Alteration of bone cell function by RANKL and OPG in different in vitro models

Lin, J., Callon, K. E., Lin, C. Q.-X., Bava, U., Zheng, M., Reid, I. R., & Cornish, J. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01800.x · Cited by 21

The Osterix Transcription Factor Down-Regulates Interleukin-1α Expression in Mouse Osteosarcoma Cells

Cao, Y., Jia, S.-F., Chakravarty, G., Crombrugghe, B. D., & Kleinerman, E. S. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0090 · Cited by 19

Circulating osteoprotegerin and receptor activator of NF-κB ligand system in patients with β-thalassemia major

Angelopoulos, N., Goula, A., Katounda, E., Rombopoulos, G., Kaltzidou, V., Kaltsas, D., Malaktari, S., Athanasiou, V., & Tolis, G. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0728-6 · Cited by 21

Osteoprotegerin Abrogates Chronic Alcohol Ingestion-Induced Bone Loss in Mice

Zhang, J., Dai, J., Lin, D., Habib, P., Smith, P., Murtha, J., Fu, Z., Yao, Z., Qi, Y., & Keller, E. T. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.7.1256 · Cited by 20

Prostate‐specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor‐KappaB ligand expression by human osteoblasts

Yonou, H., Horiguchi, Y., Ohno, Y., Namiki, K., Yoshioka, K., Ohori, M., Hatano, T., & Tachibana, M. (2007) · The Prostate · doi:10.1002/pros.20574 · Cited by 20

rDRAK1, a Novel Kinase Related to Apoptosis, Is Strongly Expressed in Active Osteoclasts and Induces Apoptosis

Kojima, H., Nemoto, A., Uemura, T., Honma, R., Ogura, M., & Liu, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101023200 · Cited by 20

Effects of Endogenous and Exogenous Prostaglandin E2 on the Proliferation and Differentiation of a Mouse Cementoblast Cell Line (OCCM‐30)

Mada, Y., Miyauchi, M., Oka, H., Kitagawa, M., Sakamoto, K., Iizuka, S., Sato, S., Noguchi, K., Somerman, M. J., & Takata, T. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.060148 · Cited by 20

Localization of Osteoprotegerin (OPG) on Bone Surfaces and Cement Lines in Rat Tibia

Nakamura, H., Tsuji, T., Hirata, A., & Yamamoto, T. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000708 · Cited by 20

Concentration of osteoprotegerin (OPG) in peritoneal fluid is increased in women with endometriosis

Harada, M., Osuga, Y., Hirata, T., Hirota, Y., Koga, K., Yoshino, O., Morimoto, C., Fujiwara, T., Momoeda, M., Yano, T., et al. (2004) · Human Reproduction · doi:10.1093/humrep/deh412 · Cited by 20

Pepstatin A, an Aspartic Proteinase Inhibitor, Suppresses RANKL-Induced Osteoclast Differentiation

Yoshida, H., Okamoto, K., Iwamoto, T., Sakai, E., Kanaoka, K., Hu, J.-P., Shibata, M., Hotokezaka, H., Nishishita, K., Mizuno, A., et al. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj066 · Cited by 23

Exosomal Osteoclast-Derived miRNA in Rheumatoid Arthritis: From Their Pathogenesis in Bone Erosion to New Therapeutic Approaches

Pascual-García, S., Martínez-Peinado, P., Pujalte-Satorre, C., Navarro‐Sempere, A., Esteve-Girbés, J., López-Jaén, A. B., Javaloyes-Antón, J., Cobo, R., Navarro-Blasco, F. J., & Sempere-Ortells, J. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031506 · Cited by 19

The Paired-box Homeodomain Transcription Factor Pax6 Binds to the Upstream Region of the TRAP Gene Promoter and Suppresses Receptor Activator of NF-κB Ligand (RANKL)-induced Osteoclast Differentiation

Kogawa, M., Hisatake, K., Atkins, G. J., Findlay, D. M., Enoki, Y., Sato, T., Gray, P. C., Kanesaki-Yatsuka, Y., Anderson, P., Wada, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.461848 · Cited by 19

Mechanical forces regulate stem cell response to surface topography

Saldaña, L., Crespo, L., Bensiamar, F., Arruebo, M., & Vilaboa, N. E. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34674 · Cited by 19

Extra virgin olive oil in maternal diet increases osteogenic genes expression, but high amounts have deleterious effects on bones in mice offspring at adolescence.

Mousavi, S. N., Koohdani, F., Eslaminejad, M. B., Izadi, P., Eshraghian, M., Sayahpour, F. A., Neek, L. S., & Shidfar, F. (2016) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2016.7915 · Cited by 19

Pasteurella multocida Toxin Triggers RANKL-Independent Osteoclastogenesis

Chakraborty, S., Kloos, B., Harre, U., Schett, G., & Kubatzky, K. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00185 · Cited by 20

Combining information from multiple bone turnover markers as diagnostic indices for osteoporosis using support vector machines

Zhang, T., Liu, P., Zhang, Y., Wang, W., Lu, Y., Xi, M., Duan, S., & Guan, F. (2018) · Biomarkers · doi:10.1080/1354750x.2018.1539767 · Cited by 19

New Insights into the Control of Cell Fate Choices and Differentiation by Retinoic Acid in Cranial, Axial and Caudal Structures

Draut, H., Liebenstein, T., & Begemann, G. (2019) · Biomolecules · doi:10.3390/biom9120860 · Cited by 18

Regulation of OPG and RANKL expressed by human dental follicle cells in osteoclastogenesis

Sun, H., Li, Q., Zhang, Y., Bi, Y., Li, X., Shu, Y., Chen, X., Jin, Z., & Cheng, G. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2214-8 · Cited by 19

Central Control of Bone Mass: Brainstorming of the Skeleton

Amling, M., Pogoda, P., Beil, F. T., Schilling, A. F., Holzmann, T., Priemel, M., Blicharski, D., Catalá-Lehnen, P., Rueger, J. M., Ducy, P. F., et al. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0651-5_9 · Cited by 18

Depth and volume of resorption induced by osteoclasts generated in the presence of RANKL, TNF-alpha/IL-1 or LIGHT

Mabilleau, G., Pascaretti‐Grizon, F., Baslé, M. F., & Chappard, D. (2011) · Cytokine · doi:10.1016/j.cyto.2011.11.014 · Cited by 20

Regulation of Osteoprotegerin Gene Expression in Dental Follicle Cells

Wise, G. E., Ren, Y.-F., & Yao, S. (2003) · Journal of Dental Research · doi:10.1177/154405910308200411 · Cited by 19

New trends in the treatment of bone metastasis

Keller, E. T., Dai, J., Escara-Wilke, J. F., Hall, C. L., Ignatoski, K. M. W., Taichman, R. S., & Keller, J. M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21540 · Cited by 20

The role of osteogenic cells in the pathophysiology of paget's disease

Robey, P. G., & Bianco, P. (1999) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650140204 · Cited by 19

Effects of alpha-calcitonin gene-related peptide on osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in MG-63 osteoblast-like cells exposed to polyethylene particles

Xu, J., Kauther, M. D., Hartl, J., Wedemeyer, C., & Study was performed at the University of Duisburg - Essen, G. (2010) · Journal of Orthopaedic Surgery and Research · doi:10.1186/1749-799x-5-83 · Cited by 18

Influence of Parathyroidectomy on Bone Metabolism and Bone Pain in Patients with Secondary Hyperparathyroidism

Schneider, R., Steinmetz, C., Karakas, E., Bartsch, D. K., & Schlosser, K. (2018) · European Surgical Research · doi:10.1159/000486172 · Cited by 18

The role of the RANKL/RANK/OPG system in the central nervous systems (CNS)

Hanada, R. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01143-9 · Cited by 18

Angiotensin II Induces Aortic Rupture and Dissection in Osteoprotegerin‐Deficient Mice

Tsuruda, T., Yamashita, A., Otsu, M., Koide, M., Nakamichi, Y., Sekita‐Hatakeyama, Y., Hatakeyama, K., Funamoto, T., Chosa, E., Asada, Y., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025336 · Cited by 17

The role of secreted osteoclastogenic factor of activated T cells in bone remodeling

Zhang, R., Peng, S., & Zhu, G. (2022) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2022.07.001 · Cited by 19

Development of an Orally Active Small-Molecule Inhibitor of Receptor Activator of Nuclear Factor-κB Ligand

Yang, K., Li, S., Wang, T., Yan, X., Qian, H., Ning, R., Xu, X. Y., Yao, W., Zhang, X., Yang, C., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00081 · Cited by 17

Sinomenine Inhibits Orthodontic Tooth Movement and Root Resorption in Rats and Enhances Osteogenic Differentiation of PDLSCs

Li, H., Li, Y., Zou, J., Yang, Y., Han, R., & Zhang, J. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s379468 · Cited by 18

Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility

Brandi, M., & Cavalli, L. (2012) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s7688 · Cited by 18

Alpha-Calcitonin Gene-Related Peptide Can Reverse The Catabolic Influence Of UHMWPE Particles On RANKL Expression In Primary Human Osteoblasts

Kauther, M. D., Xu, J., & Wedemeyer, C. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.525 · Cited by 18

The Role of the Osteoprotegerin/RANKL/RANK System in Diabetic Vascular Disease

Grigoropoulou, P., Eleftheriadou, I., Zoupas, C., & Tentolouris, N. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797535281 · Cited by 18

Expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in root resorption induced by heavy force in rats

Zhou, J. P., Feng, G. L., W.W, Z., Ren, A. S., Wu, Y., Zhang, D. M., & Dai, H. (2011) · Journal of Orofacial Orthopedics / Fortschritte der Kieferorthopädie · doi:10.1007/s00056-011-0050-3 · Cited by 18

Does the OPG/RANKL system contribute to the bone-vascular axis in chronic kidney disease? A systematic review

Znorko, B., Oksztulska-Kolanek, E., Michałowska, M., Kaminski, T. W., & Pawlak, K. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.08.001 · Cited by 19

Effect of OPG gene mutation on protein expression and biological activity in osteoporosis

Qin, S., Zhang, Q., & Li, Z. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4712 · Cited by 18

miR‐302a‐3p regulates RANKL expression in human mandibular osteoblast‐like cells

Irwandi, R. A., Khonsuphap, P., Limlawan, P., & Vacharaksa, A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26456 · Cited by 18

IL-17 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas

Me, R., Gao, N., Dai, C., & Yu, F. X. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900736 · Cited by 18

Effect of Granulocyte Colony-Stimulating Factor on Bone Metabolism During Peripheral Blood Stem Cell Mobilization

Watanabe, T., Suzuya, H., Onishi, T., Kanai, S., Kaneko, M., Watanabe, H., Nakagawa, R., Kawano, Y., Takaue, Y., Kuroda, Y., et al. (2003) · International Journal of Hematology · doi:10.1007/bf02982606 · Cited by 18

Breakthrough in bone: the molecular mechanism of osteoclast/osteoblast coupling revealed

Schwarz, E. M., & O’Keefe, R. J. (2000) · Current Opinion in Orthopedics · doi:10.1097/00001433-200010000-00001 · Cited by 17

Osteoblast Biology

Lian, J. B., & Stein, G. S. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50003-9 · Cited by 18

Osteoprotegerin in Sputum Is a Potential Biomarker in COPD

To, M., Ito, K., Ausín, P., Kharitonov, S. A., & Barnes, P. J. (2010) · CHEST Journal · doi:10.1378/chest.10-1608 · Cited by 17

Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma

de Voogd, F. A. E., Gearry, R. B., Mulder, C. J., & Day, A. S. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13324 · Cited by 17

Interleukin-20 Acts as a Promotor of Osteoclastogenesis and Orthodontic Tooth Movement

Liu, Y., Ai, Y., Sun, X., Meng, B., Chen, X., Wu, D., Gan, L., Yang, B., Fu, C., Wu, Y., et al. (2021) · Stem Cells International · doi:10.1155/2021/5539962 · Cited by 17

The Expression of IL-6 by Osteoblasts Is Increased in Healthy Elderly Individuals: Stimulated Proliferation and Differentiation Are Unaffected by Age

Eriksen, C. G., Olsen, H., Husted, L. B., Sørensen, L., Carstens, M., Søballé, K., & Langdahl, B. L. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9412-x · Cited by 17

Arctigenin Inhibits Osteoclast Differentiation and Function by Suppressing Both Calcineurin-Dependent and Osteoblastic Cell-Dependent NFATc1 Pathways

Yamashita, T., Uehara, S., Udagawa, N., Li, F., Kadota, S., Esumi, H., Kobayashi, Y., & Takahashi, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085878 · Cited by 18

Variations in Circulating Osteoprotegerin and Soluble RANKL during Diurnal and Menstrual Cycles in Young Women

Shimizu, M., Onoe, Y., 三雲, 美., Miyabara, Y., Kuroda, T., Yoshikata, R., Ishitani, K., Okano, H., & Ohta, H. (2009) · Hormone Research in Paediatrics · doi:10.1159/000208802 · Cited by 17

Regulatory Effect of Parathyroid Hormone on sRANKL‐Osteoprotegerin in Hemodialysis Patients With Renal Bone Disease

Doumouchtsis, K., Perrea, D. N., Doumouchtsis, S. K., Tziamalis, M. P., Poulakou, M. V., Vlachos, I. S., & Kostakis, A. (2009) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2009.00653.x · Cited by 17

The final pathogenetic steps in focal bone erosions in rheumatoid arthritis

Goldring, S. R. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i72 · Cited by 17

Temporal and Spatial Localization of Osteoclasts in Colonies from Embryonic Stem Cells

Hemmi, H., Okuyama, H., Yamane, T., Nishikawa, S., Nakano, T., Yamazaki, H., Kunisada, T., & Hayashi, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4153 · Cited by 17

Investigation of Salivary RANKL and OPG Levels in Periodontitis Patients at Hospital Universiti Sains Malaysia

Asif, S., Ahmad, B., Hamza, S. A., Taib, H., Kassim, N. K., & Zainuddin, S. L. A. (2021) · European Journal of Dentistry · doi:10.1055/s-0041-1731930 · Cited by 16

Enhancement of Crude Bone Morphogenetic Protein-Induced New Bone Formation and Normalization of Endochondral Ossification by Bisphosphonate Treatment in Osteoprotegerin-Deficient Mice

Tabuchi, M., Miyazawa, K., Kimura, M., Maeda, H., Kawai, T., Kameyama, Y., & Goto, S. (2005) · Calcified Tissue International · doi:10.1007/s00223-004-0223-9 · Cited by 16

Osteoimmunology — Bidirectional dialogue and inevitable union of the fields of bone and immunity —

Takayanagi, H. (2020) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.96.013 · Cited by 19

Critical issues of PTH assays in CKD

Komaba, H., Goto, S., & Fukagawa, M. (2008) · Bone · doi:10.1016/j.bone.2008.12.016 · Cited by 16

Skeletal resistance to parathyroid hormone as a background abnormality in uremia

Fukagawa, M., Iwasaki, Y., & Kazama, J. J. (2003) · Nephrology · doi:10.1046/j.1440-1797.8.s.7.x · Cited by 16

Sinusoidal electromagnetic fields promote bone formation and inhibit bone resorption in rat femoral tissuesin vitro

Zhou, J., Ma, X., Gao, Y., Yan, J., Shi, W., Xian, C. J., & Chen, K. (2014) · Electromagnetic Biology and Medicine · doi:10.3109/15368378.2014.971958 · Cited by 16

Induction of osteoblastic differentiation of neural crest-derived stem cells from hair follicles

Urano-Morisawa, E., Takami, M., Suzawa, T., Matsumoto, A., Osumi, N., Baba, K., & Kamijo, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174940 · Cited by 16

Vdr expression in osteoclast precursors is not critical in bone homeostasis

Verlinden, L., Janssens, I., Doms, S., Vanhevel, J., Carmeliet, G., & Verstuyf, A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105478 · Cited by 16

Role of phytate and osteopontin in the mechanism of soft tissue calcification

Grases, F., Prieto, R., Sanchís, P., Saus, C., & Francisco, T. D. (2008) · Journal of Nephrology · doi:10.1093/joneph/21.5.768 · Cited by 16

Corticosteroid-Induced Osteoporosis

Clarke, B. L. (2012) · American Journal of Clinical Dermatology · doi:10.2165/11594250-000000000-00000 · Cited by 16

Roles of osteoclasts and bone-derived IGFs in the survival and growth of human breast cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice

Sangai, T., Fujimoto, H., Miyamoto, S., Maeda, H., Nakamura, M., Ishii, G., Nagai, K., Nagashima, T., Miyazaki, M., & Ochiai, A. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9144-8 · Cited by 17

Immuno-PCR Assay for Homodimeric Osteoprotegerin

Furuya, D., Kaneko, R., Yagihashi, A., Endoh, T., Yajima, T., Kobayashi, D., Yano, K., Tsuda, E., & Watanabe, N. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.8.1475 · Cited by 16

Vitamin D gene regulation

Christakos, S., & Pike, J. W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00030-0 · Cited by 17

Involvement of p38MAP kinase in bone morphogenetic protein-4-induced osteoprotegerin in mouse bone-marrow-derived stromal cells

Tazoe, M., Mogi, M., Goto, S., & Togari, A. (2003) · Archives of Oral Biology · doi:10.1016/s0003-9969(03)00100-6 · Cited by 16

Circasemidian rather than circadian variation of circulating osteoprotegerin in clinical health

Tarquini, R., Mazzoccoli, G., Dolenti, S., Gaudiano, P., Comuni, C., Laffi, G., Perfetto, F., Otsuka, K., Cornélissen, G., & Franz Halberg, A. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(05)80036-8 · Cited by 16

Mechanisms of erosion in rheumatoid arthritis.

Ritchlin, C. T. (2004) · PubMed · Cited by 16

A novel molecular mechanism modulating osteoclast differentiation and function

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Goto, M., Mochizuki, S.-I., Tsuda, E., Morinaga, T., Udagawa, N., et al. (1999) · Bone · doi:10.1016/s8756-3282(99)00121-0 · Cited by 264

Osteoclast Differentiation Factor is a Ligand for Osteoprotegerin / Osteoclastogenesis-Inhibitory Factor

Shima, N., Yasuda, H., Nakagawa, N., Yamaguchi, K., Tsuda, E., Morinaga, T., Suda, T., & Higashio, K. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46869-7_43 · Cited by 1

Recent Advance in Osteoclastogenesis Inhibitory Factor.

Zhi, H. (2000) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS

16. Lack of antagonist activity of melanocyte-stimulating hormone (MSH) on the actions of IL-1 on human bone-derived osteoblast-like cells

Evans, D., Thavarajah, M., & Kanis, J. A. (1991) · Bone · doi:10.1016/8756-3282(91)90112-v

Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells

Takai, H., Kanematsu, M., Yano, K., Tsuda, E., Higashio, K., Ikeda, K., Watanabe, K., & Yamada, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27091 · Cited by 299